282 related articles for article (PubMed ID: 12585566)
21. Risperidone-induced hyperprolactinemia in adolescents: A case series.
Madhusoodanan S; Moise D
J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455
[TBL] [Abstract][Full Text] [Related]
22. Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia.
Lawford BR; Barnes M; Connor JP; Heslop K; Nyst P; Young RM
J Psychopharmacol; 2012 Feb; 26(2):324-9. PubMed ID: 21262859
[TBL] [Abstract][Full Text] [Related]
23. Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.
Young RM; Lawford BR; Barnes M; Burton SC; Ritchie T; Ward WK; Noble EP
Br J Psychiatry; 2004 Aug; 185():147-51. PubMed ID: 15286066
[TBL] [Abstract][Full Text] [Related]
24. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
Roke Y; van Harten PN; Boot AM; Buitelaar JK
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
[TBL] [Abstract][Full Text] [Related]
25. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():69-82. PubMed ID: 12650682
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Markianos M; Hatzimanolis J; Lykouras L
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
[TBL] [Abstract][Full Text] [Related]
27. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
28. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
Byerly M; Suppes T; Tran QV; Baker RA
J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
[TBL] [Abstract][Full Text] [Related]
30. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
[TBL] [Abstract][Full Text] [Related]
31. Elevation of prolactin levels by atypical antipsychotics.
Turrone P; Kapur S; Seeman MV; Flint AJ
Am J Psychiatry; 2002 Jan; 159(1):133-5. PubMed ID: 11772702
[TBL] [Abstract][Full Text] [Related]
32. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
[TBL] [Abstract][Full Text] [Related]
33. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
Lai YC; Chiou CC; Chen CH; Huang MC
J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
[No Abstract] [Full Text] [Related]
34. Prolactin awareness: an essential consideration for physical health in schizophrenia.
Montejo AL
Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
[TBL] [Abstract][Full Text] [Related]
35. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
Chen CK; Huang YS; Ree SC; Hsiao CC
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
[TBL] [Abstract][Full Text] [Related]
37. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia.
Dickson RA; Dalby JT; Williams R; Edwards AL
Am J Psychiatry; 1995 Jul; 152(7):1102-3. PubMed ID: 7540803
[No Abstract] [Full Text] [Related]
38. [Hyperprolactinemia in mentally ill patients].
Carvalho MM; Góis C
Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
[TBL] [Abstract][Full Text] [Related]
39. Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients.
Yasui-Furukori N; Furukori H; Sugawara N; Tsuchimine S; Fujii A; Inoue Y; Kaneko S
Hum Psychopharmacol; 2010 Apr; 25(3):236-42. PubMed ID: 20373475
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports.
Haddad PM; Hellewell JS; Wieck A
J Psychopharmacol; 2001 Dec; 15(4):293-5. PubMed ID: 11769824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]